Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

720 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Winnipeg, Manitoba, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Aix-en-Provence, France
View all 34 locations
View Trial Details
Completed

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

NCT00805389

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site La Louvière, Belgium
  • GSK Investigational Site Wilrijk, Belgium
View all 14 locations
View Trial Details
Completed

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

NCT00984139

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Pforzheim, Baden-Wurttemberg, Germany
View all 24 locations
View Trial Details
Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

NCT00197184

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Barcelona, Spain
View Trial Details

Related conditions